This compound is an impurity of trilaciclib, used as a reference standard in pharmaceutical intermediate synthesis. It features a tetracyclic structure with a spiro cyclohexane ring and a chlorine substituent.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1374635-90-1
3-(chloromethyl)-2-(1-isopropyl-1H-pyrazol-5-yl)pyridine hydrochloride
pharmaceutical intermediate synthesis
1-N-Boc-pyrrolidin-2-ylboronic acid
pharmaceutical intermediate synthesis
(2R,3S,4S)-2,3,4-Tris(benzyloxy)-4-(4-((benzyloxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-(4-methylpiperazin-1-yl)butan-1-one oxalate
pharmaceutical intermediate synthesis
Ethyl (I+-R,I2S)-I2-(benzoylamino)-I+--hydroxybenzenepropanoate
pharmaceutical intermediate synthesis
(2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanol
Pharmaceutical intermediate
Tert-butyl 4-(6-((7-cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
Pharmaceutical intermediate for synthesis
TERT-BUTYL (2R,3R)-3-AMINO-2-METHYLPYRROLIDINE-1-CARBOXYLATE
Pharmaceutical intermediate
2-fluoro-4-iodobenzonitrile
Pharmaceutical intermediate
4-chlorospiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one
WTRKUZNZMDTKIX-UHFFFAOYSA-N
C1CCC2(CC1)CNC(=O)C3=CC4=CN=C(N=C4N23)Cl